Scarica l'app Stockscreener
15.09
1.69%
-0.26
Dopo l'orario di chiusura:
14.95
-0.14
-0.93%
Mink Therapeutics Inc Borsa (INKT) Ultime notizie
News impact scoring models applied to MiNK Therapeutics Inc.2025 Risk Factors & AI Forecasted Entry and Exit Points - newser.com
Is MiNK Therapeutics Inc. stock poised for growthWeekly Trade Recap & Free Low Drawdown Momentum Trade Ideas - newser.com
Market Fear: How do insiders feel about MiNK Therapeutics IncMarket Movement Recap & Smart Allocation Stock Tips - khodrobank.com
How to escape a deep drawdown in MiNK Therapeutics Inc.2025 Market WrapUp & Stock Timing and Entry Methods - newser.com
Street Watch: What is the target price for MiNK Therapeutics Inc stock2025 Fundamental Recap & Intraday High Probability Alerts - khodrobank.com
Published on: 2025-09-19 10:42:21 - khodrobank.com
Can technical indicators confirm MiNK Therapeutics Inc.’s reversalTrade Entry Report & AI Forecasted Entry/Exit Points - newser.com
Is MiNK Therapeutics Inc. reversing from oversold territory2025 Risk Factors & Real-Time Stock Entry Alerts - newser.com
Real time scanner hits for MiNK Therapeutics Inc. explainedTrade Exit Report & Consistent Profit Alerts - newser.com
MiNK Therapeutics (NASDAQ:INKT) Trading Down 0.9%Should You Sell? - MarketBeat
Is MiNK Therapeutics Inc. stock ready for a breakoutQuarterly Earnings Report & Fast Exit and Entry Trade Guides - newser.com
Short Interest in MiNK Therapeutics, Inc. (NASDAQ:INKT) Decreases By 32.9% - MarketBeat
MiNK Therapeutics Appoints Dr. Terese C. Hammond to Accelerate iNKT Pipeline to Pivotal Development - GlobeNewswire
Published on: 2025-09-19 01:53:11 - khodrobank.com
MiNK Therapeutics Appoints Dr. Terese Hammond to Head Inflammatory and Pulmonary Diseases as it Prepares for Grant-Funded Clinical Trials in GVHD and Severe Pulmonary Inflammatory Disease - Quiver Quantitative
Leading Pulmonary Disease Expert Dr. Hammond Joins MiNK to Advance Revolutionary iNKT Cell Therapy - Stock Titan
Technical signs of recovery in MiNK Therapeutics Inc.Weekly Investment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Multi asset correlation models including MiNK Therapeutics Inc.Market Growth Review & Free AI Powered Buy and Sell Recommendations - newser.com
MiNK Therapeutics, Inc. (NASDAQ:INKT) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Returns Recap: What is the target price for MiNK Therapeutics Inc stockSell Signal & Technical Confirmation Alerts - خودرو بانک
Aug EndMonth: Is MiNK Therapeutics Inc forming bullish engulfing patternsProfit Target & Low Risk Investment Opportunities - khodrobank.com
Buyout Rumor: Will MiNK Therapeutics Inc benefit from government policyEarnings Overview Summary & Verified Swing Trading Watchlist - خودرو بانک
Published on: 2025-09-16 15:27:06 - newser.com
Automated trading signals detected on MiNK Therapeutics Inc.2025 Breakouts & Breakdowns & Smart Allocation Stock Tips - newser.com
Trade Report: Is MiNK Therapeutics Inc. stock forming a triangle patternJuly 2025 Gainers & Entry Point Confirmation Alerts - khodrobank.com
What recovery options are there for MiNK Therapeutics Inc.2025 Major Catalysts & Weekly Sector Rotation Insights - newser.com
Market Outlook: Is ORRF showing insider buyingMarket Growth Review & Weekly Watchlist for Consistent Profits - خودرو بانک
Published on: 2025-09-15 23:30:12 - newser.com
Trade Report: Is MiNK Therapeutics Inc stock heavily shorted2025 Earnings Surprises & Low Risk Entry Point Tips - khodrobank.com
Short interest data insights for MiNK Therapeutics Inc.July 2025 Weekly Recap & High Conviction Buy Zone Alerts - newser.com
Published on: 2025-09-14 11:55:22 - newser.com
Published on: 2025-09-14 01:44:24 - newser.com
Is it time to cut losses on MiNK Therapeutics Inc.July 2025 Snapshot & Target Return Focused Picks - newser.com
1.43%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):